October 23, 2016 12:12 PM ET


Company Overview of Mithridion, Inc.

Company Overview

Mithridion, Inc., a biopharmaceutical company, discovers and develops drugs for central nervous system disorders. Its products include MCD-386 Pharmacology, a selective M1 muscarinic agonist for alzheimer’s disease. The company’s drugs are used for the treatment of alzheimer’s disease and schizophrenia. Mithridion, Inc. was founded in 2004 and is based in Madison, Wisconsin.

505 Science Drive

Suite C

Madison, WI 53711

United States

Founded in 2004





Key Executives for Mithridion, Inc.

Co-Founder, Chairman and Chief Executive Officer
Operations Director, Secretary and Treasurer
Head of Toledo Operations and Director
Chief Medical Officer and Vice President of Drug Development
Vice President of Chemistry
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mithridion, Inc., please visit www.mithridion.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.